Tianjin Pharmaceutical Da Ren Tang Group Corporation LimitedSSE: 600329

Notice on Convening the 2nd Extraordinary General Meeting in 2025

· Issued by Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited via Shanghai Stock Exchange

Filed with SSE · · 6 pages · Chinese

Summary by 6ix AI

The meeting is scheduled to take place in December and will include both on-site and online voting options. Key agenda items for the meeting include proposals for revising company regulations and appointing auditors. Shareholders must register to attend the meeting and can delegate their voting rights to representatives.

Written in English by 6ix AI from the company’s Chinese-language filing. How 6ix writes summaries

Release

Notice on Convening the 2nd Extraordinary General Meeting in 2025

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:

Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited on 6ix

Earlier from Tianjin Pharmaceutical Da Ren Tang

Later from Tianjin Pharmaceutical Da Ren Tang

All Tianjin Pharmaceutical Da Ren Tang news releases